Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1998-9-15
pubmed:abstractText
CYFRA 21-1 is a fragment of cytokeratin 19 (CK 19). Four patients with large intrahepatic (or peripheral) cholangiocarcinoma (CC) and high serum levels of CYFRA 21-1 (normal, < or = 2 ng/ml) are reported. CYFRA 21-1 levels exceeded 9 ng/ml in all 4 patients. Carcinoembryonic antigen (CEA), was high in 1 (CEA; normal range, < or = 5.0 ng/ml) and carbohydrate antigen 19-9 (CA 19-9) was high in 3 (CA19-9; normal range, < or = 36 U/ml). We also measured serum levels of CYFRA 21-1 in 13 patients with hepatocellular carcinoma (HCC) more than 5 cm in diameter. Levels of CYFRA 21-1 exceeded 2 ng/ml in 9 of the HCC patients and were higher than 9 ng/ml in 2 of the HCC patients. Levels of alpha fetoprotein (AFP) and/or protein induced by vitamin K absence or antagonist II (PIVKA II) were elevated in all HCC patients (AFP, PIVKA II, respectively; normal range, < or = 10.0 ng/ml and < or = 0.1 AU/ml) CYFRA 21-1 levels were measured twice or three times during the clinical course in 2 CC patients and in 6 HCC patients, and increased gradually with tumor growth in the 2 CC patients and in 3 of the 6 HCC patients. Marked increases in serum CYFRA 21-1 levels in patients with large liver cancers, particularly in those with normal levels of AFP and PIVKA II, would suggest the existence of intrahepatic CC rather than HCC.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0944-1174
pubmed:author
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
447-53
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:9658330-Antigens, Neoplasm, pubmed-meshheading:9658330-Bile Duct Neoplasms, pubmed-meshheading:9658330-Bile Ducts, Intrahepatic, pubmed-meshheading:9658330-Biological Markers, pubmed-meshheading:9658330-Carcinoma, Hepatocellular, pubmed-meshheading:9658330-Cholangiocarcinoma, pubmed-meshheading:9658330-Diagnosis, Differential, pubmed-meshheading:9658330-Female, pubmed-meshheading:9658330-Humans, pubmed-meshheading:9658330-Keratin-19, pubmed-meshheading:9658330-Keratins, pubmed-meshheading:9658330-Liver Neoplasms, pubmed-meshheading:9658330-Male, pubmed-meshheading:9658330-Middle Aged, pubmed-meshheading:9658330-Protein Precursors, pubmed-meshheading:9658330-Prothrombin, pubmed-meshheading:9658330-Tomography, X-Ray Computed, pubmed-meshheading:9658330-Tumor Markers, Biological, pubmed-meshheading:9658330-alpha-Fetoproteins
pubmed:year
1998
pubmed:articleTitle
Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level.
pubmed:affiliation
Department of Internal Medicine, Itami City Hospital, Japan.
pubmed:publicationType
Journal Article, Case Reports